HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference d4beae86bf
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
132 acceptance records as first applicant, grouped into 59 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Edaravone and Dexborneol Concentrated Solution for Injection 1 records · Latest accepted 2026/11/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602732 | Generic | 2026/11/06 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Oxaliplatin Injection 2 records · Latest accepted 2026/11/05
Generic · 2
Calcium Gluconate Injection 1 records · Latest accepted 2026/10/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602590 | Generic | 2026/10/22 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/07/08
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601633 | Generic | 2026/07/08 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2100166 | Generic | 2021/02/05 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Potassium Phosphates Injection 1 records · Latest accepted 2026/07/02
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601253 | Supplement | 2026/07/02 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Zhi He (Shandong) Da Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
Landiolol Hydrochloride for Injection 1 records · Latest accepted 2026/06/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601362 | Generic | 2026/06/10 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Lactated Ringer's Injection 1 records · Latest accepted 2026/05/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600857 | Supplement | 2026/05/01 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/04/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600939 | Generic | 2026/04/24 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Erythromycin Lactobionate for Injection 2 records · Latest accepted 2026/04/08
Generic · 2
No verified English name 20 records · Latest accepted 2026/03/21
Supplement · 20
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600559 | Supplement | 2026/03/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2600558 | Supplement | 2026/03/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2600557 | Supplement | 2026/03/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2600556 | Supplement | 2026/03/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2600555 | Supplement | 2026/03/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2600554 | Supplement | 2026/03/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2600553 | Supplement | 2026/03/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2400268 | Supplement | 2024/02/20 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2302144 | Supplement | 2023/09/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2302143 | Supplement | 2023/09/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2302142 | Supplement | 2023/09/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2301223 | Supplement | 2023/05/30 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2301222 | Supplement | 2023/05/30 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2201938 | Supplement | 2022/10/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2201937 | Supplement | 2022/10/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2201936 | Supplement | 2022/10/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2200689 | Supplement | 2022/04/26 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2101639 | Supplement | 2021/07/28 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2101638 | Supplement | 2021/07/28 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2101637 | Supplement | 2021/07/28 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Asenapine Maleate Sublingual Tablets 5 records · Latest accepted 2026/03/13
Generic · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600659 | Generic | 2026/03/13 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHS2402669 | Generic | 2024/08/16 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHS2402668 | Generic | 2024/08/16 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHL2200043 | Generic | 2022/05/10 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHL2200042 | Generic | 2022/05/10 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
No verified English name 13 records · Latest accepted 2026/01/31
Supplement · 13
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600204 | Supplement | 2026/01/31 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2400267 | Supplement | 2024/02/19 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2302150 | Supplement | 2023/09/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2302149 | Supplement | 2023/09/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2301230 | Supplement | 2023/05/30 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2201935 | Supplement | 2022/10/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2201934 | Supplement | 2022/10/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2200690 | Supplement | 2022/04/26 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2200540 | Supplement | 2022/03/22 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2101419 | Supplement | 2021/06/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2101222 | Supplement | 2021/05/10 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2101221 | Supplement | 2021/05/10 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2101220 | Supplement | 2021/05/10 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/01/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600315 | Generic | 2026/01/30 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
No verified English name 3 records · Latest accepted 2026/01/15
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600072 | Supplement | 2026/01/15 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2600071 | Supplement | 2026/01/15 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2600070 | Supplement | 2026/01/15 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Finerenone Tablets 2 records · Latest accepted 2025/12/04
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504169 | Generic | 2025/12/04 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2504168 | Generic | 2025/12/04 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/10/17
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502073 | Supplement | 2025/10/17 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Zhong Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2502072 | Supplement | 2025/10/17 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Zhong Fu Pharma Co., Ltd. romanized | CDE ↗ |
No verified English name 3 records · Latest accepted 2025/10/17
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502080 | Supplement | 2025/10/17 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Zhong Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2502079 | Supplement | 2025/10/17 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Zhong Fu Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2502078 | Supplement | 2025/10/17 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Zhong Fu Pharma Co., Ltd. romanized | CDE ↗ |
Levofloxacin and Sodium Chloride Injection 3 records · Latest accepted 2025/10/14
Supplement · 2Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502017 | Supplement | 2025/10/14 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2302677 | Supplement | 2023/12/06 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHS2102078 | Generic | 2021/11/24 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/09/10
Generic · 2
No verified English name 2 records · Latest accepted 2025/08/16
Generic · 2
Peramivir Injection 1 records · Latest accepted 2025/08/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502916 | Generic | 2025/08/12 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/08/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501562 | Supplement | 2025/08/07 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Trazodone Hydrochloride Sustained-release Tablets 1 records · Latest accepted 2025/08/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502782 | Generic | 2025/08/02 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Paracetamol and Ibuprofen Tablets 1 records · Latest accepted 2025/06/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501980 | Generic | 2025/06/05 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Aminophylline Tablets 1 records · Latest accepted 2025/03/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500988 | Generic | 2025/03/10 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Ruxolitinib Phosphate Tablets 3 records · Latest accepted 2025/01/20
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500362 | Generic | 2025/01/20 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2500361 | Generic | 2025/01/20 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2500360 | Generic | 2025/01/20 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Aripiprazole Orally Disintegrating tablets 4 records · Latest accepted 2024/12/27
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404560 | Generic | 2024/12/27 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHS2404559 | Generic | 2024/12/27 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHS2200101 | Generic | 2022/01/17 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHS2200100 | Generic | 2022/01/17 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
No verified English name 2 records · Latest accepted 2024/12/18
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402155 | Supplement | 2024/12/18 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Haerbin Yu Heng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2402154 | Supplement | 2024/12/18 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Haerbin Yu Heng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Vardenafil Hydrochloride Orally disintegrating Tablets 1 records · Latest accepted 2024/12/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404392 | Generic | 2024/12/18 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Metformin Hydrochloride Tablets 1 records · Latest accepted 2024/12/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402134 | Supplement | 2024/12/13 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Betahistine Mesilate Tablets 1 records · Latest accepted 2024/11/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404092 | Generic | 2024/11/28 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Moxifloxacin Hydrochloride And Sodium Chloride Injection 2 records · Latest accepted 2024/11/07
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401839 | Supplement | 2024/11/07 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2400799 | Supplement | 2024/06/12 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Brexpiprazole Tablets 4 records · Latest accepted 2024/08/23
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402764 | Generic | 2024/08/23 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2402763 | Generic | 2024/08/23 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2402259 | Generic | 2024/07/18 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2402257 | Generic | 2024/07/18 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
No verified English name 4 records · Latest accepted 2024/07/02
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450349 | Supplement | 2024/07/02 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2450348 | Supplement | 2024/07/02 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2450347 | Supplement | 2024/07/02 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2101209 | Supplement | 2021/05/12 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/06/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450332 | Supplement | 2024/06/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Fluconazole and Sodium Chloride Injection 1 records · Latest accepted 2024/06/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401716 | Generic | 2024/06/07 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Nimodipine Tablets 1 records · Latest accepted 2024/05/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401587 | Generic | 2024/05/28 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Metronidazole and Sodium Chloride Injection 2 records · Latest accepted 2023/12/05
Supplement · 1Generic · 1
Sodium Bicarbonate Injection 1 records · Latest accepted 2023/11/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350850 | Supplement | 2023/11/18 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Carbazochrome Sodium Sulfonate Injection 2 records · Latest accepted 2023/08/26
Supplement · 2
No verified English name 2 records · Latest accepted 2023/07/29
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302026 | Generic | 2023/07/29 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2302025 | Generic | 2023/07/29 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Potassium Chloride Injection 3 records · Latest accepted 2023/07/06
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350533 | Supplement | 2023/07/06 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2350285 | Supplement | 2023/03/24 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2201551 | Supplement | 2022/08/25 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Ambroxol Hydrochloride Injection 3 records · Latest accepted 2023/07/01
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301453 | Supplement | 2023/07/01 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2301452 | Supplement | 2023/07/01 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2301451 | Supplement | 2023/07/01 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Pentoxifylline Injection 1 records · Latest accepted 2023/02/16
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350188 | Supplement | 2023/02/16 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Triptorelin Acetate Injection 1 records · Latest accepted 2023/02/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300399 | Generic | 2023/02/08 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Lornoxicam for Injection 1 records · Latest accepted 2023/01/06
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350023 | Supplement | 2023/01/06 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/01/04
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300009 | Supplement | 2023/01/04 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/01/04
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300008 | Supplement | 2023/01/04 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Esmolol Hydrochloride Injection 1 records · Latest accepted 2022/12/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2202135 | Generic | 2022/12/29 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Multiple Electrolytes Injection(Ⅱ) 1 records · Latest accepted 2022/11/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2240039 | Supplement | 2022/11/18 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Alanyl Glutamine Injection 4 records · Latest accepted 2022/08/16
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250506 | Supplement | 2022/08/16 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2250505 | Supplement | 2022/08/16 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2250402 | Supplement | 2022/06/29 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHB2250401 | Supplement | 2022/06/29 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Olanzapine Tablets 1 records · Latest accepted 2022/06/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200979 | Generic | 2022/06/30 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/06/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200821 | Generic | 2022/06/10 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Ozagrel Sodium Injection 2 records · Latest accepted 2021/12/22
Generic · 2
Gabexate Mesilate For Injection 1 records · Latest accepted 2021/12/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2151060 | Supplement | 2021/12/09 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Clindamycin Injection 1 records · Latest accepted 2021/09/06
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150858 | Supplement | 2021/09/06 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Mecobalamin Injection 1 records · Latest accepted 2021/05/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150626 | Supplement | 2021/05/25 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Omeprazole Sodium for Injection 1 records · Latest accepted 2021/03/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150155 | Supplement | 2021/03/09 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Olanzapine Orally Disintegrating Tablets 2 records · Latest accepted 2021/02/24
Generic · 2
Changes in the last 90 days
5 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Marketing application approved: 1 applicationAccepted: 4 applications
- 2026/11/06Accepted
Edaravone and Dexborneol Concentrated Solution for Injection
CYHS2602732
Fact date: 2026/11/06 · Site observation date: 2026/11/07
View source ↗ - 2026/11/05Accepted
Oxaliplatin Injection
CYHS2602705
Fact date: 2026/11/05 · Site observation date: 2026/11/06
View source ↗ - 2026/11/05Accepted
Oxaliplatin Injection
CYHS2602703
Fact date: 2026/11/05 · Site observation date: 2026/11/06
View source ↗ - 2026/10/22Accepted
Calcium Gluconate Injection
CYHS2602590
Fact date: 2026/10/22 · Site observation date: 2026/10/23
View source ↗ - 2026/10/20Marketing application approved
Aminophylline Tablets
CYHS2500988 · 国药准字H20266376
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
View source · Table row 40 ↗
Under review
31 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Edaravone and Dexborneol Concentrated Solution for Injection | CYHS2602732 | Generic | 2026/11/06 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Oxaliplatin Injection | CYHS2602705 | Generic | 2026/11/05 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Oxaliplatin Injection | CYHS2602703 | Generic | 2026/11/05 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Calcium Gluconate Injection | CYHS2602590 | Generic | 2026/10/22 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHS2601633 | Generic | 2026/07/08 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Landiolol Hydrochloride for Injection | CYHS2601362 | Generic | 2026/06/10 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Lactated Ringer's Injection | CYHB2600857 | Supplement | 2026/05/01 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHS2600939 | Generic | 2026/04/24 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Erythromycin Lactobionate for Injection | CYHS2600795 | Generic | 2026/04/08 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Erythromycin Lactobionate for Injection | CYHS2600794 | Generic | 2026/04/08 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600559 | Supplement | 2026/03/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600558 | Supplement | 2026/03/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600557 | Supplement | 2026/03/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600556 | Supplement | 2026/03/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600555 | Supplement | 2026/03/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600554 | Supplement | 2026/03/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600553 | Supplement | 2026/03/21 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Asenapine Maleate Sublingual Tablets | CYHS2600659 | Generic | 2026/03/13 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600204 | Supplement | 2026/01/31 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600072 | Supplement | 2026/01/15 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600071 | Supplement | 2026/01/15 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600070 | Supplement | 2026/01/15 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Finerenone Tablets | CYHS2504169 | Generic | 2025/12/04 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Finerenone Tablets | CYHS2504168 | Generic | 2025/12/04 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | CYHS2503357 | Generic | 2025/09/10 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHS2503355 | Generic | 2025/09/10 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | CYHS2503015 | Generic | 2025/08/16 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHS2503014 | Generic | 2025/08/16 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Peramivir Injection | CYHS2502916 | Generic | 2025/08/12 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Trazodone Hydrochloride Sustained-release Tablets | CYHS2502782 | Generic | 2025/08/02 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Paracetamol and Ibuprofen Tablets | CYHS2501980 | Generic | 2025/06/05 | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.; Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Catalogue holder records
41 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Ruxolitinib Phosphate Tablets | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | 国药准字H20265691 | 2026/08/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ozagrel Sodium Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20265351 | 2026/07/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vardenafil Hydrochloride Orally disintegrating Tablets | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20264808 | 2026/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Betahistine Mesilate Tablets | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | 国药准字H20264353 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Aripiprazole Orally Disintegrating tablets | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20264325 | 2026/05/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Aripiprazole Orally Disintegrating tablets | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20264324 | 2026/05/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fluconazole and Sodium Chloride Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20255667 | 2025/10/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nimodipine Tablets | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | 国药准字H20255229 | 2025/08/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20045789 | 2025/07/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20258074 | 2025/05/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20183171 | 2025/05/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20258075 | 2025/05/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Carbazochrome Sodium Sulfonate Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20258048 | 2025/03/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | 国药准字H20253086 | 2025/01/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | 国药准字H20253087 | 2025/01/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sodium Bicarbonate Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20247252 | 2024/10/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Triptorelin Acetate Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20244823 | 2024/09/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ambroxol Hydrochloride Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20247085 | 2024/04/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Esmolol Hydrochloride Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20243401 | 2024/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Potassium Chloride Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20084537 | 2024/03/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Olanzapine Tablets | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | 国药准字H20243092 | 2024/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lornoxicam for Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20057160 | 2024/01/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pentoxifylline Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H200330670 | 2023/12/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Multiple Electrolytes Injection(Ⅱ) | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20223508 | 2023/07/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Alanyl Glutamine Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20044899 | 2023/07/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Alanyl Glutamine Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20044900 | 2023/07/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Levofloxacin and Sodium Chloride Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20233783 | 2023/06/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gabexate Mesilate For Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20058489 | 2022/11/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Metronidazole and Sodium Chloride Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20223772 | 2022/10/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olanzapine Orally Disintegrating Tablets | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20223374 | 2022/06/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olanzapine Orally Disintegrating Tablets | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20223373 | 2022/06/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Clindamycin Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20056967 | 2022/05/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Edaravone Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20223281 | 2022/05/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mecobalamin Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20044627 | 2022/03/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Omeprazole Sodium for Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20057630 | 2021/12/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ambroxol Hydrochloride Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20183195 | 2021/11/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ambroxol Hydrochloride Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20217116 | 2021/11/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ondansetron Hydrochloride Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20059359 | 2021/10/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ozagrel Sodium Injection | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20265352 | 2026/07/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ruxolitinib Phosphate Tablets | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | 国药准字H20265692 | 2026/08/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ruxolitinib Phosphate Tablets | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized | 国药准字H20265693 | 2026/08/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
171 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Acetaminophen Injection | CYHS2601934 | Generic | 2026/08/07 | Shandong Bai Nuo Pharmaceuticals Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Isoniazid Injection | CYHB2601054 | Supplement | 2026/06/04 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Isoniazid Injection | CYHB2601053 | Supplement | 2026/06/04 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600980 | Supplement | 2026/05/20 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600979 | Supplement | 2026/05/20 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600978 | Supplement | 2026/05/20 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600977 | Supplement | 2026/05/20 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600974 | Supplement | 2026/05/20 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600973 | Supplement | 2026/05/20 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600971 | Supplement | 2026/05/19 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600970 | Supplement | 2026/05/19 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Verapamil Hydrochloride Injection | CYHB2600967 | Supplement | 2026/05/19 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Nefopam Hydrochloride Injection | CYHB2600966 | Supplement | 2026/05/19 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600953 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600952 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600951 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600950 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Lincomycin Injection | CYHB2600944 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Lincomycin Injection | CYHB2600943 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Lidocaine Hydrochloride Injection | CYHB2600942 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Lidocaine Hydrochloride Injection | CYHB2600941 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600940 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Cimetidine Injection | CYHB2600939 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600938 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600937 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600936 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600935 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600934 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600933 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600932 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600931 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600930 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600929 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600925 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600924 | Supplement | 2026/05/14 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600920 | Supplement | 2026/05/13 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600919 | Supplement | 2026/05/13 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600918 | Supplement | 2026/05/13 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600911 | Supplement | 2026/05/13 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600810 | Supplement | 2026/04/23 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600808 | Supplement | 2026/04/23 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600807 | Supplement | 2026/04/23 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600806 | Supplement | 2026/04/23 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600805 | Supplement | 2026/04/23 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600804 | Supplement | 2026/04/23 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600725 | Supplement | 2026/04/10 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600724 | Supplement | 2026/04/10 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600711 | Supplement | 2026/04/09 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Sodium Bicarbonate Injection | CYHB2600705 | Supplement | 2026/04/09 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Sodium Bicarbonate Injection | CYHB2600704 | Supplement | 2026/04/09 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600698 | Supplement | 2026/04/08 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600697 | Supplement | 2026/04/08 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600694 | Supplement | 2026/04/08 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600692 | Supplement | 2026/04/04 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600691 | Supplement | 2026/04/04 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600689 | Supplement | 2026/04/04 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600686 | Supplement | 2026/04/04 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600685 | Supplement | 2026/04/04 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600684 | Supplement | 2026/04/04 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Calcium Gluconate Injection | CYHB2600676 | Supplement | 2026/04/03 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Calcium Gluconate Injection | CYHB2600675 | Supplement | 2026/04/03 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Calcium Gluconate Injection | CYHB2600674 | Supplement | 2026/04/03 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Amikacin Sulfate injection | CYHB2600631 | Supplement | 2026/03/31 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Amikacin Sulfate injection | CYHB2600630 | Supplement | 2026/03/31 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600627 | Supplement | 2026/03/31 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600625 | Supplement | 2026/03/30 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600624 | Supplement | 2026/03/30 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600582 | Supplement | 2026/03/25 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600581 | Supplement | 2026/03/25 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600580 | Supplement | 2026/03/25 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600579 | Supplement | 2026/03/25 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Furosemide Injection | CYHB2600347 | Supplement | 2026/02/13 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600336 | Supplement | 2026/02/11 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600335 | Supplement | 2026/02/11 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Chlorphenamine Maleate Injection | CYHB2600301 | Supplement | 2026/02/10 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Chlorphenamine Maleate Injection | CYHB2600300 | Supplement | 2026/02/10 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Magnesium Sulfate Injection | CYHB2600299 | Supplement | 2026/02/10 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Magnesium Sulfate Injection | CYHB2600298 | Supplement | 2026/02/10 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Magnesium Sulfate Injection | CYHB2600296 | Supplement | 2026/02/10 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600295 | Supplement | 2026/02/10 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Atropine Sulfate Injection | CYHB2600263 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Atropine Sulfate Injection | CYHB2600262 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Atropine Sulfate Injection | CYHB2600261 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Atropine Sulfate Injection | CYHB2600260 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600258 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600257 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600256 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600254 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600253 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600252 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600251 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Potassium Chloride Injection | CYHB2600250 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Gentamicin Sulfate Injection | CYHB2600249 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Gentamicin Sulfate Injection | CYHB2600248 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Gentamicin Sulfate Injection | CYHB2600247 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600246 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600245 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Tobramycin Sulfate Injection | CYHB2600244 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Tobramycin Sulfate Injection | CYHB2600243 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600242 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600241 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600240 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600239 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Rifamycin Sodium Injection | CYHB2600238 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Rifamycin Sodium Injection | CYHB2600237 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600236 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600235 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600234 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600233 | Supplement | 2026/02/06 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Aminophylline Injection | CYHB2600223 | Supplement | 2026/02/04 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Aminophylline Injection | CYHB2600222 | Supplement | 2026/02/04 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Aminophylline Injection | CYHB2600221 | Supplement | 2026/02/04 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Piracetam Injection | CYHB2600215 | Supplement | 2026/02/03 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Piracetam Injection | CYHB2600214 | Supplement | 2026/02/03 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Citicoline Sodium Injection | CYHB2600211 | Supplement | 2026/01/31 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Citicoline Sodium Injection | CYHB2600210 | Supplement | 2026/01/31 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600209 | Supplement | 2026/01/31 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600208 | Supplement | 2026/01/31 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Dexamethasone Sodium Phosphate Injection | CYHB2600207 | Supplement | 2026/01/31 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Dexamethasone Sodium Phosphate Injection | CYHB2600206 | Supplement | 2026/01/31 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600205 | Supplement | 2026/01/31 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600203 | Supplement | 2026/01/31 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600202 | Supplement | 2026/01/31 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Tranexamic Acid Injection | CYHB2600200 | Supplement | 2026/01/31 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Tranexamic Acid Injection | CYHB2600199 | Supplement | 2026/01/31 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600167 | Supplement | 2026/01/28 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600166 | Supplement | 2026/01/28 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600165 | Supplement | 2026/01/28 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2600148 | Supplement | 2026/01/24 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Tigecycline for Injection | CYHB2600007 | Supplement | 2026/01/05 | Chongqing Shi Sen Pharmaceuticals Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2502605 | Supplement | 2025/12/29 | Ha Yao Group Bio Gong Cheng Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Indocyaninegreen for Injection | CYHS2504164 | Generic | 2025/12/04 | Chongqing Shi Sen Pharmaceuticals Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Levofloxacin and Sodium Chloride Injection | CYHB2501920 | Supplement | 2025/09/28 | Chongqing An Nuo Sheng Sheng Ming Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Levofloxacin and Sodium Chloride Injection | CYHB2501919 | Supplement | 2025/09/28 | Chongqing An Nuo Sheng Sheng Ming Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Levofloxacin and Sodium Chloride Injection | CYHB2501918 | Supplement | 2025/09/28 | Chongqing An Nuo Sheng Sheng Ming Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Moxifloxacin Hydrochloride And Sodium Chloride Injection | CYHS2503504 | Generic | 2025/09/24 | Chongqing An Nuo Sheng Sheng Ming Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2501480 | Supplement | 2025/07/24 | Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Calcium Gluconate in Sodium Chloride Injection | CYHS2502367 | Generic | 2025/07/04 | Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Isosorbide Dinitrate Injection | CYHS2501462 | Generic | 2025/04/17 | Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Levofloxacin and Sodium Chloride Injection | CYHB2500261 | Supplement | 2025/02/08 | Chongqing An Nuo Sheng Sheng Ming Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Levofloxacin and Sodium Chloride Injection | CYHB2500259 | Supplement | 2025/02/08 | Chongqing An Nuo Sheng Sheng Ming Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Lactated Ringer's Injection | CYHS2500408 | Generic | 2025/01/22 | Chongqing An Nuo Sheng Sheng Ming Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Isosorbide Dinitrate Injection | CYHS2500234 | Generic | 2025/01/10 | Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Omeprazole Sodium for Injection | CYHB2402259 | Supplement | 2025/01/01 | Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Terlipressin for Injection | CYHS2404610 | Generic | 2024/12/28 | Tianjin Hong Ri Pharma Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Thymalfasin for Injection | CYHB2450637 | Supplement | 2024/12/27 | Tianjin Hong Ri Pharma Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Moxifloxacin Hydrochloride And Sodium Chloride Injection | CYHS2403767 | Generic | 2024/11/05 | Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHS2403607 | Generic | 2024/10/25 | Xizang Ao Si Bi Xiu Pharmaceuticals Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHS2403356 | Generic | 2024/10/10 | Shenyang Xing Qi Yan Yao Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Fluorouracil Injection | CYHB2401328 | Supplement | 2024/08/26 | Guo Yao Yi Xin Pharmaceutical Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Fluorouracil Injection | CYHB2401327 | Supplement | 2024/08/26 | Guo Yao Yi Xin Pharmaceutical Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Polymyxin B sulfate for Injection | CYHS2402521 | Generic | 2024/08/08 | Hunan Ai Wei Ge Lin Pharmaceuticals Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2401049 | Supplement | 2024/07/16 | Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2401048 | Supplement | 2024/07/16 | Lan Xi Ha San Lian Pharmaceutical Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHS2401405 | Generic | 2024/05/11 | Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Raltitrexed for Injection | CYHS2400880 | Generic | 2024/03/21 | Shandong Bai Nuo Pharmaceuticals Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Sodium Ibandronate Injection | CYHB2350899 | Supplement | 2023/11/29 | Tianjin Hong Ri Pharma Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Sodium Ibandronate Injection | CYHB2350898 | Supplement | 2023/11/29 | Tianjin Hong Ri Pharma Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Potassium Chloride Injection | CYHS2301136 | Generic | 2023/04/24 | Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Potassium Chloride Injection | CYHS2301135 | Generic | 2023/04/24 | Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Octreotide Acetate Injection | CYHB2300477 | Supplement | 2023/03/07 | Zai Wei Pharma (Hainan) Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2300385 | Supplement | 2023/02/23 | Zhongguo Da Zhong Pharmaceutical Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Levofloxacin and Sodium Chloride Injection | CYHS2300261 | Generic | 2023/01/31 | Ji Chuan Pharma Group Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Levofloxacin and Sodium Chloride Injection | CYHS2300260 | Generic | 2023/01/31 | Ji Chuan Pharma Group Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2201820 | Supplement | 2022/10/01 | Zhong Fu Pharma Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Tigecycline for Injection | CYHS2201617 | Generic | 2022/09/27 | Chongqing Shi Sen Pharmaceuticals Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Famotidine Injection | CYHS2201520 | Generic | 2022/09/15 | Chongqing Shi Sen Pharmaceuticals Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| No verified English name | CYHB2200626 | Supplement | 2022/04/19 | Zhong Fu Pharma Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Oseltamivir Phosphate For Oral Suspension | CYHS2200237 | Generic | 2022/01/29 | Guangdong Wan Fang Pharma Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Oseltamivir Phosphate For Oral Suspension | CYHS2200236 | Generic | 2022/01/29 | Guangdong Wan Fang Pharma Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| Octreotide Acetate Injection | CYHS2101496 | Generic | 2021/07/30 | Beijing Shi Xin Li Cheng Pharmaceuticals Technology Co., Ltd. romanized; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.